| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | 20.13▼ | 20.11▲ |
| MA10 | N/A | N/A | N/A | 20.12▲ | N/A |
| MA20 | N/A | N/A | N/A | 20.11▲ | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | 53.662▲ | N/A |
| STOCH | N/A | N/A | N/A | 62.780 | N/A |
| WILL %R | N/A | N/A | N/A | -37.143 | N/A |
| CCI | N/A | N/A | N/A | 3.200 | N/A |
|
Thursday, January 29, 2026 04:18 AM
CRISPR Therapeutics AG (NASDAQ:CRSP) is among the Growth Stock Portfolio: 12 Stock Picks By Cathie Wood. On January 22, 2026, TheFly disclosed that Alec Stranahan, a BofA analyst. It reduced the price ...
|
|
Tuesday, December 30, 2025 08:56 PM
CRISPR Therapeutics AG (NASDAQ:CRSP) is among the 12 Best Genomics Stocks to Invest In. TheFly published on November 26, 2025, that Chardan kept its buy recommendation on CRISPR Therapeutics AG ...
|
|
Tuesday, December 30, 2025 04:56 AM
Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the “Contrarius Global Equity Fund”. A copy of the letter can be downloaded here. The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/01/26 | 20.125 | 20.125 | 20.125 | 20.125 | 4 |
| 27/01/26 | 20.145 | 20.145 | 20.145 | 20.145 | 4 |
| 26/01/26 | 20.165 | 20.165 | 20.165 | 20.165 | 3 |
| 23/01/26 | 20.11 | 20.11 | 20.11 | 20.11 | 3 |
| 22/01/26 | 20.105 | 20.105 | 20.105 | 20.105 | 3 |
| 21/01/26 | 20.085 | 20.085 | 20.085 | 20.085 | 4 |
| 20/01/26 | 20.015 | 20.015 | 20.015 | 20.015 | 3 |
| 16/01/26 | 20.115 | 20.115 | 20.115 | 20.115 | 3 |
| 15/01/26 | 20.17 | 20.17 | 20.17 | 20.17 | 3 |
| 14/01/26 | 20.18 | 20.19 | 20.18 | 20.19 | 160 |
|
|
||||
|
|
||||
|
|